Abstract
Nuclear Medicine (NM) has evolved into an integrated medical specialty that encompasses molecular imaging, quantitative functional evaluation, radiopharmaceutical technologies, and targeted radionuclide therapies. Unlike conventional radiography, which primarily explores structural and morphological abnormalities, NM employs radiopharmaceuticals to explore physiological, biochemical, and/or molecular processes at the cellular level.
With the development of hybrid imaging technologies, theranostics, artificial intelligence (AI), and precision medicine, it has evolved from diagnostic imaging to a personalized medical specialty integrating diagnosis and targeted therapy.
NM is recognized as an autonomous specialty because of its unique scientific foundations, specialized educational curriculum, specialized infrastructure, and internationally recognized certification processes. A worldwide shortage of dedicated NM-qualified personnel poses a challenge to NM sustainability despite significant scientific advances. Workforce shortages have emerged as a major barrier to the expansion of hybrid imaging, including positron emission tomography/computed tomography (PET/CT), single photon emission computed tomography (SPECT/CT), and theranostic applications. An aging workforce, limited training capacity, growing procedural complexity, and expanding indications for molecular imaging have created significant workforce constraints that directly affect diagnostic capability, patient access, and the adoption of precision medicine. This review emphasizes the scientific foundations, expanding clinical applications, and growing need for dedicated training amid the workforce crisis, supporting the recognition of NM as an autonomous specialty in Pakistan.